These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 18222354)

  • 1. A kinesin family member 6 variant is associated with coronary heart disease in the Women's Health Study.
    Shiffman D; Chasman DI; Zee RY; Iakoubova OA; Louie JZ; Devlin JJ; Ridker PM
    J Am Coll Cardiol; 2008 Jan; 51(4):444-8. PubMed ID: 18222354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of the Trp719Arg polymorphism in kinesin-like protein 6 with myocardial infarction and coronary heart disease in 2 prospective trials: the CARE and WOSCOPS trials.
    Iakoubova OA; Tong CH; Rowland CM; Kirchgessner TG; Young BA; Arellano AR; Shiffman D; Sabatine MS; Campos H; Packard CJ; Pfeffer MA; White TJ; Braunwald E; Shepherd J; Devlin JJ; Sacks FM
    J Am Coll Cardiol; 2008 Jan; 51(4):435-43. PubMed ID: 18222353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival bias and drug interaction can attenuate cross-sectional case-control comparisons of genes with health outcomes. An example of the kinesin-like protein 6 (KIF6) Trp719Arg polymorphism and coronary heart disease.
    Williams P; Pendyala L; Superko R
    BMC Med Genet; 2011 Mar; 12():42. PubMed ID: 21435211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of pravastatin therapy on coronary events in carriers of the KIF6 719Arg allele from the cholesterol and recurrent events trial.
    Shiffman D; Sabatine MS; Louie JZ; Kirchgessner TG; Iakoubova OA; Campos H; Devlin JJ; Sacks FM
    Am J Cardiol; 2010 May; 105(9):1300-5. PubMed ID: 20403483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymorphism in KIF6 gene and benefit from statins after acute coronary syndromes: results from the PROVE IT-TIMI 22 study.
    Iakoubova OA; Sabatine MS; Rowland CM; Tong CH; Catanese JJ; Ranade K; Simonsen KL; Kirchgessner TG; Cannon CP; Devlin JJ; Braunwald E
    J Am Coll Cardiol; 2008 Jan; 51(4):449-55. PubMed ID: 18222355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. KIF6 Trp719Arg polymorphism and the effect of statin therapy in elderly patients: results from the PROSPER study.
    Iakoubova OA; Robertson M; Tong CH; Rowland CM; Catanese JJ; Blauw GJ; Jukema JW; Murphy MB; Devlin JJ; Ford I; Shepherd J
    Eur J Cardiovasc Prev Rehabil; 2010 Aug; 17(4):455-61. PubMed ID: 20215968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The 719Arg variant of KIF6 and cardiovascular outcomes in statin-treated, stable coronary patients of the treating to new targets and incremental decrease in end points through aggressive lipid-lowering prospective studies.
    Arsenault BJ; Boekholdt SM; Hovingh GK; Hyde CL; DeMicco DA; Chatterjee A; Barter P; Deedwania P; Waters DD; LaRosa JC; Pedersen TR; Kastelein JJ;
    Circ Cardiovasc Genet; 2012 Feb; 5(1):51-7. PubMed ID: 22135385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. KIF6 polymorphism as a predictor of risk of coronary events and of clinical event reduction by statin therapy.
    Li Y; Iakoubova OA; Shiffman D; Devlin JJ; Forrester JS; Superko HR
    Am J Cardiol; 2010 Oct; 106(7):994-8. PubMed ID: 20854963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinesin-like protein 6 (KIF6) polymorphism and the efficacy of rosuvastatin in primary prevention.
    Ridker PM; MacFadyen JG; Glynn RJ; Chasman DI
    Circ Cardiovasc Genet; 2011 Jun; 4(3):312-7. PubMed ID: 21493817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meta-analyses of KIF6 Trp719Arg in coronary heart disease and statin therapeutic effect.
    Peng P; Lian J; Huang RS; Xu L; Huang Y; Ba Y; Yang X; Huang X; Dong C; Zhang L; Ye M; Zhou J; Duan S
    PLoS One; 2012; 7(12):e50126. PubMed ID: 23236363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The contribution of a 9p21.3 variant, a KIF6 variant, and C-reactive protein to predicting risk of myocardial infarction in a prospective study.
    Shiffman D; O'Meara ES; Rowland CM; Louie JZ; Cushman M; Tracy RP; Devlin JJ; Psaty BM
    BMC Cardiovasc Disord; 2011 Mar; 11():10. PubMed ID: 21406102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation of KIF6 Trp719Arg in a case-control study of myocardial infarction: a Costa Rican population.
    Bare LA; Ruiz-Narvaéz EA; Tong CH; Arellano AR; Rowland CM; Catanese JJ; Sacks FM; Devlin JJ; Campos H
    PLoS One; 2010 Sep; 5(9):. PubMed ID: 20927332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Trp719Arg polymorphism of the KIF6 gene and coronary heart disease risk: systematic review and meta-analysis.
    Ruiz-Ramos D; Hernández-Díaz Y; Tovilla-Zárate CA; Juárez-Rojop I; López-Narváez ML; González-Castro TB; Torres-Hernández ME; Baños-González MA
    Hereditas; 2015; 152():3. PubMed ID: 28096762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. No impact of KIF6 genotype on vascular risk and statin response among 18,348 randomized patients in the heart protection study.
    Hopewell JC; Parish S; Clarke R; Armitage J; Bowman L; Hager J; Lathrop M; Collins R;
    J Am Coll Cardiol; 2011 May; 57(20):2000-7. PubMed ID: 21458191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of KIF6 Trp719Arg in a case-control study of coronary artery disease in Western Indians.
    Bhanushali AA; Contractor A; Shah VT; Das BR
    Genet Test Mol Biomarkers; 2011 Dec; 15(12):883-6. PubMed ID: 21810021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of KIF6 variant with lipid level and angiographic coronary artery disease events risk in the Han Chinese population.
    Wu G; Li GB; Dai B
    Molecules; 2012 Sep; 17(9):11269-80. PubMed ID: 23001387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic variants in the KIF6 region and coronary event reduction from statin therapy.
    Li Y; Sabatine MS; Tong CH; Ford I; Kirchgessner TG; Packard CJ; Robertson M; Rowland CM; Bare LA; Shepherd J; Devlin JJ; Iakoubova OA
    Hum Genet; 2011 Jan; 129(1):17-23. PubMed ID: 20886236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. KIF6, LPA, TAS2R50, and VAMP8 genetic variation, low density lipoprotein cholesterol lowering response to pravastatin, and heart disease risk reduction in the elderly.
    Akao H; Polisecki E; Kajinami K; Trompet S; Robertson M; Ford I; Jukema JW; de Craen AJ; Westendorp RG; Shepherd J; Packard C; Buckley BM; Schaefer EJ
    Atherosclerosis; 2012 Feb; 220(2):456-62. PubMed ID: 22192511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Sickle Cell Trait With Incidence of Coronary Heart Disease Among African American Individuals.
    Hyacinth HI; Franceschini N; Seals SR; Irvin MR; Chaudhary N; Naik RP; Alonso A; Carty CL; Burke GL; Zakai NA; Winkler CA; David VA; Kopp JB; Judd SE; Adams RJ; Gee BE; Longstreth WT; Egede L; Lackland DT; Greenberg CS; Taylor H; Manson JE; Key NS; Derebail VK; Kshirsagar AV; Folsom AR; Konety SH; Howard V; Allison M; Wilson JG; Correa A; Zhi D; Arnett DK; Howard G; Reiner AP; Cushman M; Safford MM
    JAMA Netw Open; 2021 Jan; 4(1):e2030435. PubMed ID: 33399855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between KIF6 rs20455 polymorphism and the risk of coronary heart disease (CHD): a pooled analysis of 50 individual studies including 40,059 cases and 64,032 controls.
    Li Y; Chen Z; Song H
    Lipids Health Dis; 2018 Jan; 17(1):4. PubMed ID: 29304815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.